Medical News

RSS

Global Health Partner utilizes existing share purchase warrants

Global Health Partner’s (STO:GHP) CEO Per Båtelson and Deputy CEO Johan Wachtmeister have utilized existing share purchase warrants and acquired 527,444 and 527,445 shares, respectively, in Global Health Partner. The warrants were issued by a number of Global Health Partner’s shareholders, mainly by Metroland BVBA, and the strike price was 75 pence, corresponding to approximately SEK 8.75.

1 Sep 2009

Warfarin therapy provides substantial protection for elder patients with atrial fibrillation

Warfarin (an oral anticoagulant) therapy for patients with atrial fibrillation - the most common type of significant heart rhythm disorder - appears to be most beneficial for the oldest patients, for those who have had a prior stroke and for patients with multiple risk factors for stroke, according to a new study by Kaiser Permanente and Massachusetts General Hospital researchers.

1 Sep 2009

Ceragenix Pharmaceuticals updates license agreement covering antimicrobial technology use

Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the “Company”), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive evaluation and option to license agreement (the "Agreement”) with a global, multi-billion dollar healthcare company covering the use of the Company's CeraShield antimicrobial technology for a specific medical device associated with a high incidence of hospital acquired infections.

1 Sep 2009

Cigarettes and not Swedish snuff increase the risk of developing multiple sclerosis

While smoking cigarettes appears to significantly increase a person's risk of developing multiple sclerosis, using Swedish snuff does not, according to a study published in the September 1, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.

1 Sep 2009

Frontrow's new microphone improves students' presentation and comprehension skills

Classroom sound system maker, FrontRow(TM), has released a new pass-around microphone that's designed to be easier for young students to use. With special attention to fitting childrens' small hands, this unique tool provides an increased level of comfort for all students in K-12 classrooms, while providing excellent sound quality.

1 Sep 2009

Cimzia approved for treating adult patients with rheumatoid arthritis

UCB Canada Inc. announced today that Health Canada has approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).

1 Sep 2009

TransPharma's Phase 2A trial of ViaDerm-hPTH(1-34) for treating severe osteoporosis is successful

TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of the Phase 2A trial of ViaDerm-hPTH(1-34) which is being developed for the treatment of severe osteoporosis.

1 Sep 2009

Results of the first pivotal Phase III trial with pimavanserin in patients with PDP announced

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the first pivotal Phase III trial with pimavanserin in patients with Parkinson’s disease psychosis, or PDP. The study did not meet its primary endpoint of antipsychotic efficacy as measured using the Scale for the Assessment of Positive Symptoms, or SAPS.

1 Sep 2009

Biovail announces Phase III trial results for pimavanserin

Biovail Corporation today announced top-line results from ACADIA Pharmaceutical Inc.’s first pivotal Phase III trial with pimavanserin in patients with Parkinson’s disease psychosis, or PDP.

1 Sep 2009

Statement updating details on testing of IDenta-Alert explosive detectors released

International drug & explosives detection firm IDenta Corp. (PINKSHEETS: IDTA) releases statement updating details about US Department of Defense testing of the IDenta-Alert explosive detectors.

1 Sep 2009

LTS LOHMANN Therapie-Systeme celebrates 25th anniversary

LTS LOHMANN Therapie-Systeme AG, the leading developer and manufacturer of transdermal, topical and oral systems with facilities in Andernach, Germany and West Caldwell, New Jersey, celebrates its 25th anniversary.

1 Sep 2009

Quality Systems to present corporate strategy at the Healthcare Conference 2009

Quality Systems, Inc. announced today that its management plans to present its corporate story at the Thomas Weisel Partners Healthcare Conference 2009.

1 Sep 2009

St. Baldrick’s Foundation to organize fund raiser for childhood cancer research

Dozens of men, women and children are expected to shave their heads bald to show solidarity to children with cancer and to raise money for childhood cancer research September 19, 2009 at 5:00 at The Friendly Sons of the Shillelagh Club in West Orange, NJ.

1 Sep 2009

Chai-Na-Ta's Board of Directors approves extension of a non-revolving term loan facility

Chai-Na-Ta Corp. (the "Company"), announced that the Board of Directors of the Company has approved the extension of a non-revolving term loan facility ("Loan") of HK$ 54.7 million (approximately CAD$7.7 million) offered by More Growth Finance Limited ("More Growth"), a company formally under common control.

1 Sep 2009

NASDAQ Stock Market issues noncompliance letter to Encorium Group

Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced that on August 25, 2009, it received a letter from The NASDAQ Stock Market notifying the Company that, based on its Form 10-Q for the period ended June 30, 2009, NASDAQ has determined that the Company's stockholders' equity does not comply with the minimum $2.5 million stockholders' equity requirement for continued listing on The NASDAQ Capital Market as required by NASDAQ Marketplace Rule 5550(b)(1).

1 Sep 2009

Angel MedFlight helps liver transplant patient claim insurance for life flight transportation

Last year, Sally (a patient suffering from end stage liver failure) was in need of life flight transportation to be evaluated for a liver transplant. Her doctors told her she needed to receive the evaluation in order to get on the transplant list. Travel by ground ambulance or commercial flight were not an option due to her condition. Her health insurance company told her they would not cover the air ambulance medical transport. But last week, after four appeals and countless hours of work by Angel MedFlight's patient advocates, that decision was reversed.

1 Sep 2009

Retail clinics offer better quality care at lower costs than other venues

A new study by Rand Corporation, published in the Annals of Internal Medicine, concludes retail clinics provide quality care at lower costs and equal or better quality than other urgent care options.

1 Sep 2009

Six-month period financial results released by Cannasat Therapeutics

Cannasat Therapeutics Inc., a clinical stage pharmaceutical company developing products to treat neurological disorders such as neuropathic pain and schizophrenia, today announced its results for the six months ended June 30, 2009. Unless specified otherwise, all amounts are in Canadian dollars.

1 Sep 2009

Senator Bob Dole urges a 'fresh start' on the issue of health care reform

In today's Washington Post, Senator Bob Dole urges a 'fresh start' on the issue of health care reform and said it is "the vital issue of our time, and Obama should be out front with his specific plan on this make-or-break issue."

1 Sep 2009

Davita Chairman is one of 100 Most Powerful People in Healthcare

DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced that Modern Healthcare Magazine, one of the nation's leading health care industry publications, named Kent Thiry, Chairman and CEO for DaVita(R), as one of the 100 Most Powerful People in Healthcare in 2009.

1 Sep 2009

Medical News

Global Health Partner utilizes existing share purchase warrants

Warfarin therapy provides substantial protection for elder patients with atrial fibrillation

Ceragenix Pharmaceuticals updates license agreement covering antimicrobial technology use

Cigarettes and not Swedish snuff increase the risk of developing multiple sclerosis

Frontrow's new microphone improves students' presentation and comprehension skills

Cimzia approved for treating adult patients with rheumatoid arthritis

TransPharma's Phase 2A trial of ViaDerm-hPTH(1-34) for treating severe osteoporosis is successful

Results of the first pivotal Phase III trial with pimavanserin in patients with PDP announced

Biovail announces Phase III trial results for pimavanserin

Statement updating details on testing of IDenta-Alert explosive detectors released

LTS LOHMANN Therapie-Systeme celebrates 25th anniversary

Quality Systems to present corporate strategy at the Healthcare Conference 2009

St. Baldrick’s Foundation to organize fund raiser for childhood cancer research

Chai-Na-Ta's Board of Directors approves extension of a non-revolving term loan facility

NASDAQ Stock Market issues noncompliance letter to Encorium Group

Angel MedFlight helps liver transplant patient claim insurance for life flight transportation

Retail clinics offer better quality care at lower costs than other venues

Six-month period financial results released by Cannasat Therapeutics

Senator Bob Dole urges a 'fresh start' on the issue of health care reform

Davita Chairman is one of 100 Most Powerful People in Healthcare

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Latest News